Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Fierlbeck

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
Cancer Immunology, Immunotherapy : CII|October 1, 1994
Neutralizing interferon beta antibodies in melanoma patients treated with recombinant and natural interferon betaG Fierlbeck, T Schreiner, B Schaber, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|April 2, 1998
[Scleredema adultorum Buschke. Case report and review of the literature]A Ulmer, G Schaumburg-Lever, J Bauer, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|October 1, 1996
Pharmacodynamics of recombinant IFN-beta during long-term treatment of malignant melanomaG Fierlbeck, A Ulmer, T Schreiner, et al.
German Journal of Ophthalmology|March 1, 1996
Therapy of Behçet's diseaseI Kötter, H Dürk, J Saal, et al.
Melanoma Research|April 1, 1994
Activation of cellular cytotoxicity and complement-mediated lysis of melanoma and neuroblastoma cells in vitro by murine antiganglioside antibodies MB 3.6 and 14.G2aP Mayer, R Handgretinger, G Bruchelt, et al.
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|September 1, 1992
Determination of 2'-5'-oligoadenylate synthetase in serum and peripheral blood mononuclear cells before and after subcutaneous application of recombinant interferon beta and gammaG Bruchelt, G Fierlbeck, U Schiebel, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|January 1, 1992
[Intralesional therapy of melanoma metastases with recombinant interferon-beta]G Fierlbeck, B d'Hoedt, W Stroebel, et al.
German Journal of Ophthalmology|July 1, 1995
Behçet's disease: epidemiology and eye manifestations in German and Mediterranian patientsM Zierhut, J Saal, U Pleyer, et al.
The British Journal of Dermatology|February 21, 2008
Severe exacerbation of chronic plaque psoriasis following initially effective therapy with efalizumab: clinical characterization and therapeutic managementA Ulmer, F Wölbing, G Metzler, et al.
Archives of Dermatology|December 1, 1995
Positron emission tomography and ultrasonography. A comparative retrospective study assessing the diagnostic validity in lymph node metastases of malignant melanomaC Blessing, U Feine, L Geiger, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Cancer Immunology, Immunotherapy : CII|October 1, 1994
Neutralizing interferon beta antibodies in melanoma patients treated with recombinant and natural interferon betaG Fierlbeck, T Schreiner, B Schaber, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|April 2, 1998
[Scleredema adultorum Buschke. Case report and review of the literature]A Ulmer, G Schaumburg-Lever, J Bauer, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|October 1, 1996
Pharmacodynamics of recombinant IFN-beta during long-term treatment of malignant melanomaG Fierlbeck, A Ulmer, T Schreiner, et al.
German Journal of Ophthalmology|March 1, 1996
Therapy of Behçet's diseaseI Kötter, H Dürk, J Saal, et al.
Melanoma Research|April 1, 1994
Activation of cellular cytotoxicity and complement-mediated lysis of melanoma and neuroblastoma cells in vitro by murine antiganglioside antibodies MB 3.6 and 14.G2aP Mayer, R Handgretinger, G Bruchelt, et al.
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|September 1, 1992
Determination of 2'-5'-oligoadenylate synthetase in serum and peripheral blood mononuclear cells before and after subcutaneous application of recombinant interferon beta and gammaG Bruchelt, G Fierlbeck, U Schiebel, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|January 1, 1992
[Intralesional therapy of melanoma metastases with recombinant interferon-beta]G Fierlbeck, B d'Hoedt, W Stroebel, et al.
German Journal of Ophthalmology|July 1, 1995
Behçet's disease: epidemiology and eye manifestations in German and Mediterranian patientsM Zierhut, J Saal, U Pleyer, et al.
The British Journal of Dermatology|February 21, 2008
Severe exacerbation of chronic plaque psoriasis following initially effective therapy with efalizumab: clinical characterization and therapeutic managementA Ulmer, F Wölbing, G Metzler, et al.
Archives of Dermatology|December 1, 1995
Positron emission tomography and ultrasonography. A comparative retrospective study assessing the diagnostic validity in lymph node metastases of malignant melanomaC Blessing, U Feine, L Geiger, et al.
Pageof 8